Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Puma Biotechnology, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 132 | 151 | +19 |
| Shares | 34.4M | 35.3M | +964.7K (+2.8%) |
| Value | $182.5M | $210.2M | +$27.7M (+15.2%) |
New holders (33)
Institutions that held Puma Biotechnology, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (14)
Institutions that held Puma Biotechnology, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Marshall Wace, LLP | 557,548 | $2.96M |
| Tang Capital Management LLC | 200,000 | $1.06M |
| Wellington Management Group LLP | 149,552 | $794.1K |
| Hillsdale Investment Management Inc. | 77,800 | $413.1K |
| Assenagon Asset Management S.A. | 72,979 | $387.5K |
| Macquarie Group Ltd | 61,255 | $325.0K |
| Graham Capital Management, L.P. | 52,708 | $279.9K |
| Deutsche Bank AG | 30,743 | $163.2K |
| Sherbrooke Park Advisers LLC | 30,527 | $162.1K |
| XTX Topco Ltd | 25,524 | $135.5K |
| Sanctuary Advisors, LLC | 23,866 | $126.7K |
| Squarepoint Ops LLC | 21,334 | $113.3K |
| Luminist Capital LLC | 250 | $1.32K |
| Atlantic Union Bankshares Corp | 150 | $797 |